Beit Jala Pharmaceutical Company announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was JOD 8.689 million compared to JOD 8.814 million a year ago. Basic earnings per share from continuing operations was JOD 0.106 compared to JOD 0.195 a year ago.